201 related articles for article (PubMed ID: 35472511)
21. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Int J Pharm; 2022 Nov; 628():122320. PubMed ID: 36272514
[TBL] [Abstract][Full Text] [Related]
22. Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations.
Ballacchino G; Weaver E; Mathew E; Dorati R; Genta I; Conti B; Lamprou DA
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360832
[TBL] [Abstract][Full Text] [Related]
23. Microfluidic formulation of anticancer peptide loaded ZIF-8 nanoparticles for the treatment of breast cancer.
Qiu J; Tomeh MA; Jin Y; Zhang B; Zhao X
J Colloid Interface Sci; 2023 Jul; 642():810-819. PubMed ID: 37043939
[TBL] [Abstract][Full Text] [Related]
24. Microfluidic Preparation of Nanoparticles Using Poly(ethylene Glycol)-distearoylphosphatidylethanolamine for Solubilizing Poorly Soluble Drugs.
Terada T; Kanou M; Hashimoto Y; Tanimoto M; Sugimoto M
J Pharm Sci; 2022 Jun; 111(6):1709-1718. PubMed ID: 34863973
[TBL] [Abstract][Full Text] [Related]
25. Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers.
Maeki M; Fujishima Y; Sato Y; Yasui T; Kaji N; Ishida A; Tani H; Baba Y; Harashima H; Tokeshi M
PLoS One; 2017; 12(11):e0187962. PubMed ID: 29182626
[TBL] [Abstract][Full Text] [Related]
26. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems.
Maeki M; Kimura N; Sato Y; Harashima H; Tokeshi M
Adv Drug Deliv Rev; 2018 Mar; 128():84-100. PubMed ID: 29567396
[TBL] [Abstract][Full Text] [Related]
27. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
[TBL] [Abstract][Full Text] [Related]
28. Microfluidic Manufacturing of Polymeric Nanoparticles: Comparing Flow Control of Multiscale Structure in Single-Phase Staggered Herringbone and Two-Phase Reactors.
Xu Z; Lu C; Riordon J; Sinton D; Moffitt MG
Langmuir; 2016 Dec; 32(48):12781-12789. PubMed ID: 27934536
[TBL] [Abstract][Full Text] [Related]
29. Microfluidics for pharmaceutical nanoparticle fabrication: The truth and the myth.
Hamdallah SI; Zoqlam R; Erfle P; Blyth M; Alkilany AM; Dietzel A; Qi S
Int J Pharm; 2020 Jun; 584():119408. PubMed ID: 32407942
[TBL] [Abstract][Full Text] [Related]
30. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique.
Arduino I; Liu Z; Rahikkala A; Figueiredo P; Correia A; Cutrignelli A; Denora N; Santos HA
Acta Biomater; 2021 Feb; 121():566-578. PubMed ID: 33326887
[TBL] [Abstract][Full Text] [Related]
31. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
[TBL] [Abstract][Full Text] [Related]
32. The importance of microfluidics for the preparation of nanoparticles as advanced drug delivery systems.
Martins JP; Torrieri G; Santos HA
Expert Opin Drug Deliv; 2018 May; 15(5):469-479. PubMed ID: 29508630
[TBL] [Abstract][Full Text] [Related]
33. Robust manufacturing of lipid-polymer nanoparticles through feedback control of parallelized swirling microvortices.
Toth MJ; Kim T; Kim Y
Lab Chip; 2017 Aug; 17(16):2805-2813. PubMed ID: 28726923
[TBL] [Abstract][Full Text] [Related]
34. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics.
Martins C; Sarmento B
Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924
[TBL] [Abstract][Full Text] [Related]
35. Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics.
De A; Ko YT
Drug Deliv; 2022 Dec; 29(1):2644-2657. PubMed ID: 35949146
[TBL] [Abstract][Full Text] [Related]
36. The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution.
Nakamura T; Kawai M; Sato Y; Maeki M; Tokeshi M; Harashima H
Mol Pharm; 2020 Mar; 17(3):944-953. PubMed ID: 31990567
[TBL] [Abstract][Full Text] [Related]
37. Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers.
Le NHA; Van Phan H; Yu J; Chan HK; Neild A; Alan T
Int J Nanomedicine; 2018; 13():1353-1359. PubMed ID: 29563792
[TBL] [Abstract][Full Text] [Related]
38. Use of Microfluidics to Prepare Lipid-Based Nanocarriers.
Vogelaar A; Marcotte S; Cheng J; Oluoch B; Zaro J
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111539
[TBL] [Abstract][Full Text] [Related]
39. Volumetric Scalability of Microfluidic and Semi-Batch Silk Nanoprecipitation Methods.
Matthew SAL; Rezwan R; Perrie Y; Seib FP
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408763
[TBL] [Abstract][Full Text] [Related]
40. Microfluidic technologies for nanoparticle formation.
Tian F; Cai L; Liu C; Sun J
Lab Chip; 2022 Feb; 22(3):512-529. PubMed ID: 35048096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
